TELIGENT FDA Approval NDA 019593

NDA 019593

TELIGENT

FDA Drug Application

Application #019593

Documents

Letter2002-01-07
Letter2009-11-12
Label1999-10-29
Label2009-03-27
Label2009-10-06
Letter2003-04-30
Letter2006-07-21
Letter2009-02-19
Review2003-04-30

Application Sponsors

NDA 019593TELIGENT

Marketing Status

Discontinued001
Discontinued002

Application Products

001INJECTABLE;INJECTIONEQ 50MG BASE/100ML0ZANTAC IN PLASTIC CONTAINERRANITIDINE HYDROCHLORIDE
002INJECTABLE;INJECTIONEQ 1MG BASE/ML0ZANTAC IN PLASTIC CONTAINERRANITIDINE HYDROCHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1986-12-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1987-05-18STANDARD
LABELING; LabelingSUPPL4AP1988-01-04
LABELING; LabelingSUPPL5AP1989-03-17
LABELING; LabelingSUPPL6AP1988-05-20
LABELING; LabelingSUPPL7AP1988-05-20
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1989-08-08STANDARD
LABELING; LabelingSUPPL10AP1989-05-18
LABELING; LabelingSUPPL11AP1990-08-13
LABELING; LabelingSUPPL12AP1991-11-25
LABELING; LabelingSUPPL13AP1990-07-16
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1990-12-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1991-01-17STANDARD
LABELING; LabelingSUPPL16AP1990-11-21
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1990-12-20STANDARD
LABELING; LabelingSUPPL18AP1991-09-05
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1992-02-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1992-07-22STANDARD
LABELING; LabelingSUPPL21AP1993-04-05
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1992-08-12STANDARD
LABELING; LabelingSUPPL25AP1994-08-10STANDARD
LABELING; LabelingSUPPL26AP1994-11-03STANDARD
LABELING; LabelingSUPPL28AP1999-10-29STANDARD
LABELING; LabelingSUPPL29AP1999-10-22STANDARD
LABELING; LabelingSUPPL30AP1999-10-22STANDARD
LABELING; LabelingSUPPL31AP1999-10-29STANDARD
LABELING; LabelingSUPPL32AP2001-05-09STANDARD
LABELING; LabelingSUPPL33AP2002-01-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL34AP2002-01-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL35AP2001-12-13STANDARD
LABELING; LabelingSUPPL38AP2006-07-12STANDARD
LABELING; LabelingSUPPL39AP2009-02-17STANDARD
LABELING; LabelingSUPPL42AP2009-09-04STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL8Null0
SUPPL14Null0
SUPPL15Null0
SUPPL17Null0
SUPPL19Null0
SUPPL20Null0
SUPPL23Null0
SUPPL34Null0
SUPPL35Null0
SUPPL42Null6

CDER Filings

TELIGENT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19593
            [companyName] => TELIGENT
            [docInserts] => ["",""]
            [products] => [{"drugName":"ZANTAC IN PLASTIC CONTAINER","activeIngredients":"RANITIDINE HYDROCHLORIDE","strength":"EQ 50MG BASE\/100ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"ZANTAC IN PLASTIC CONTAINER","activeIngredients":"RANITIDINE HYDROCHLORIDE","strength":"EQ 1MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"09\/04\/2009","submission":"SUPPL-42","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/019090s053,019593s042lbl.pdf\"}]","notes":""},{"actionDate":"02\/17\/2009","submission":"SUPPL-39","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/019090s051,019593s039lbl.pdf\"}]","notes":""},{"actionDate":"10\/29\/1999","submission":"SUPPL-28","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/1999\\\/019593s028lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"ZANTAC IN PLASTIC CONTAINER","submission":"RANITIDINE HYDROCHLORIDE","actionType":"EQ 50MG BASE\/100ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"ZANTAC IN PLASTIC CONTAINER","submission":"RANITIDINE HYDROCHLORIDE","actionType":"EQ 1MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2009-09-04
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.